Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T20:59:59.989Z Has data issue: false hasContentIssue false
  • English
  • Français

P01.101 Possible mechanisms for the efficacy of olanzapine in preventing relapse in schizophrenia

Published online by Cambridge University Press:  16 April 2020

B. Jones  and
C.C. Taylor
B. Jones
Affiliation:
Lilly Research Laboratories, Eli Lilly & Company, One Lilly Corporate Center, Indianapolis, IN 46219, USA
C.C. Taylor
Affiliation:
Lilly Research Laboratories, Eli Lilly & Company, One Lilly Corporate Center, Indianapolis, IN 46219, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 15 , Issue S2: Congress of the Association of European Psychiatrists , October 2000 , pp. 347s
Copyright
Copyright © European Psychiatric Association 2000
Submit a response

Comments

No Comments have been published for this article.